CONTEXT: Our aim was to present a summary of the Second International Consultation on
Bladder Cancer recommendations on the diagnosis and treatment options for non–muscle …

Bladder cancer is the fourth most common cancer in the United States. Urothelial carcinoma
that originates from the urinary bladder is the most common subtype. These NCCN Clinical …

Purpose: We defined an optimal curative strategy for muscle invasive bladder cancer and to
determine how best to deliver curative therapy. Materials and Methods: We reviewed …

Background Radical cystectomy (RC) represents the mainstay of treatment in patients with
muscle-invasive urinary bladder cancer but how it compares with the best organ …

Context Aims of bladder preservation in muscle-invasive bladder cancer (MIBC) are to offer
a quality-of-life advantage and avoid potential morbidity or mortality of radical cystectomy …

Purpose Despite being one of the most important clinical outcomes in nonmuscle invasive
bladder cancer, there is currently no standard definition of disease progression. Major …

Background Previous randomised controlled trials comparing bladder preservation with
radical cystectomy for muscle-invasive bladder cancer closed due to insufficient accrual …

Non-muscle invasive bladder cancer (NMIBC) is a heterogeneous population of tumours
accounting for 80% of bladder cancers. Over the years, the management of this disease has …

CONTEXT AND OBJECTIVE: To present the updated version of 2008 European Association
of Urology (EAU) guidelines on non-muscle-invasive bladder cancer. EVIDENCE …

BACKGROUND: Despite its lethal potential, many patients with muscle-invasive bladder
cancer (MIBC) do not receive aggressive, potentially curative therapy consistent with …